A Novel Regimen of Transdermal Botulinum Toxin Delivery Using Fractional Microneedling Radiofrequency for Treatment of Erythema in Rosacea

Figure 2

Representative patients’ clinical photographs. Photographs were taken at visits 1 (a), 2 (b), 3 (c), and 4 (d). Case 1: A 21-year-old woman with erythema on the cheeks, nose, and supraeyebrow area. Her baseline clinician’s erythema assessment (CEA) score was 4, which decreased to 2 at visits 2–4. Case 2: A 42-year-old woman with erythema on the cheeks, nose, and supraeyebrow area. Her initial CEA score was 3, remained the same at visit 2, and decreased to 2 at visits 3 and 4. Case 3: A 37-year-old woman with erythema on the cheeks, glabella, and supraeyebrow area. Her baseline CEA score was 4, which decreased to 3 at visit 2, 2 at visit 3, and 1 at visit 4.